Arginine is an essential modulator of the cellular immune response during infection. The generation of nitric oxide (NO) from arginine by the inducible nitric oxide synthase (iNOS) is responsible for the cytotoxicity of macrophages against bacterial and parasitic pathogens (10, 25, 37) , while the conversion of arginine to ornithine and urea via the arginase pathway has been shown to support the intracellular survival of Helicobacter pylori, Leishmania spp., Trypanosoma spp., and Schistosoma spp. (1, 9, 20, 21, 28, 33, 44) . Indeed, competition between iNOS and arginase for arginine has been suggested to contribute to the outcome of infection (11, 35, 36) .
Access to arginine is important not only for infected macrophages but also for the infecting organism. A number of pathogens have been shown to alter their arginine-dependent metabolic activities when they are inside their host cells. For example, Listeria monocytogenes preferentially upregulates arpJ, a gene encoding an arginine permease, during intracellular growth (32) , Mycobacterium marinum induces the argS gene, encoding arginyl-tRNA synthetase, when inside macrophages (4) , and Giardia lamblia inhibits NO synthesis by macrophages by directly consuming arginine using a highly efficient arginine transport system (15) . Therefore, arginine availability and the capacity of the host cells and the infecting organism to acquire arginine and/or its derived substrates are important factors that can influence the course of an infection.
The genes for L-arginine biosynthesis in Mycobacterium tuberculosis and Mycobacterium bovis BCG are found in the operon argCJBDFRGH (22) . Although mycobacteria can synthesize L-arginine from glutamate, carbamoyl phosphate, and aspartate, L-arginine biosynthesis is energetically expensive as it requires at least six ATP equivalents; less energy is required for mycobacteria to acquire L-arginine from the external environment. Therefore, it is not surprising that there are several genes encoding putative L-arginine uptake systems (Rv0522, Rv2320c, Rv3253c, Rv1999c, and Rv1979c) in M. tuberculosis and M. bovis, most likely with different substrate affinities and capacities (13) . Depending on the environment in which they reside, the ability of mycobacteria to acquire L-arginine may be reflected by the amounts and types of L-arginine permeases (44) . Our laboratory is studying these permeases and related arginine metabolic enzymes to understand their role in infection by mycobacteria. Previous work from our laboratory described L-arginine transport in M. bovis BCG by examining the phenotypes of a mutant strain, AS-1, lacking a single gene encoding a cationic amino acid transporter, gabP (Rv0522), and the mutant's complemented derivative, AS-2 (44) . L-Arginine transport by AS-1 is reduced by 70% when this strain is grown in 7H9 culture medium. However, AS-1 exhibited undiminished uptake of L-lysine and L-ornithine. These results suggest that the Rv0522-encoded permease does not significantly contribute to the transport of other cationic amino acids (L-ornithine and Llysine) in BCG grown in culture. Thus, the remaining 30% of L-arginine transport activity and the uptake of other cationic amino acids by AS-1 are mediated by other amino acid permeases.
In another study we demonstrated that intracellular BCG was able to incorporate 3 H label while inside J774.1 macrophages grown in culture medium that is supplemented with 3 H-labeled L-arginine (41) . Surprisingly, the AS-1 mutant accumulated twofold more 3 H label than wild-type BCG inside J774.1 macrophages. These results suggest that intracellular AS-1, in contrast to AS-1 grown in culture, has an increased, not decreased, capacity to transport arginine or other argininederived substrates when inside the macrophages.
It has long been known that classical activation of murine macrophages leads to increased arginine transport (6, 7, 26, 31) . We showed that infection by BCG without activation does not stimulate arginine transport (40) . We also found that AS-1, but not BCG, induced L-arginine uptake in infected J774.1 cells in the absence of activation with cytokines or lipopolysaccharide (LPS) (41) .
We hypothesized that intracellular AS-1, having an induced capacity to acquire intracellular substrates derived from macrophage arginine, perturbs arginine homeostasis of the host macrophages. Thus, the aim of the present work was to study the response of resting and activated (gamma interferon [IFN-␥]-plus-LPS-treated) J774.1 macrophages to AS-1 and BCG infection by evaluating several L-arginine-dependent activities, such as L-arginine uptake and transporter expression, iNOS expression, NO production, and arginase activity. Further, we investigated the effect of modulating arginine and ornithine availability on the survival of AS-1 and BCG during growth in J774.1 macrophages. Altogether, our results show that intracellular survival of BCG depends on its arginine transport capacity and arginine availability within the host macrophages.
MATERIALS AND METHODS
Bacterial strains and growth conditions. M. bovis BCG and its derivatives AS-1 and AS-2 were grown in Middlebrook medium (Difco). Middlebrook 7H9 (liquid) and 7H11 (1.5% agar) media were supplemented with 0.5% (vol/vol) glycerol and ADC supplement (0.5% [wt/vol] bovine serum albumin, fraction V, 0.2% [wt/vol] dextrose, and 0.85% [wt/vol] NaCl). All liquid cultures of BCG were supplemented with 0.05% (vol/vol) Tween 80 (Sigma). All cultures were incubated at 37°C.
Maintenance of J774.1 murine macrophages. The J774.1 murine macrophage cell line was maintained at 37°C, 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM; Sigma) containing 10% (vol/vol) fetal bovine serum (Sigma), 2 mM glutamine (Sigma), and essential amino acids (Gibco BRL).
Processing of BCG for infection. BCG cultures (optical density at 600 nm of 0.7 to 0.8, approximating that of the logarithmic growth phase) were used for infection of macrophages. Ten milliliters of bacterial suspension was diluted to 50-ml volume in phosphate-buffered saline (PBS) and centrifuged at 5,000 ϫ g for 15 min at room temperature. The bacterial pellet was resuspended in DMEM (above). Bacterial clumps were disaggregated by vortexing five times with 3-mm sterile glass beads (Fisher Scientific) for 2 min. The bacterial suspension was passed through a 5-m filter (Micron Separation Inc.) to remove remaining clumps and then aliquoted (1 ml) and stored at Ϫ80°C. Representative vials were thawed, serially diluted, and then plated on 7H11 medium to determine the number of viable bacilli by counting CFU.
Mycobacterial infection of J774.1 murine macrophages. J774.1 macrophages were detached from the tissue culture flasks by gentle scraping with a cell scraper (Costar). J774.1 cells (1 ϫ 10 5 /well) were distributed in 24-well tissue culture plates and allowed to adhere overnight prior to infection. Frozen stocks of the BCG strains were thawed and prewarmed to 37°C and were added to the macrophages at 5:1 mycobacteria per macrophage (multiplicity of infection, 5:1). The macrophages were allowed to phagocytose the bacteria for 2 h, after which time nonphagocytosed organisms were removed by washing three times with prewarmed serum-free medium. Infected J774.1 cell lines were maintained in culture for 3 days.
Uptake of L-[ 3 H]arginine in J774.1 macrophages. J774.1 macrophages were exposed to the following experimental conditions: (i) stimulation with IFN-␥ plus LPS (100 U/ml and 1 g/ml, respectively); (ii) infection with BCG, AS- (40) .
Macrophage cultures were washed three times with 200 l of ice-cold PBS containing 10 mM unlabeled L-arginine. After washing, 100 l of 0.024 M formic acid was added to each well to lyse the macrophage monolayer. The macrophage lysate was mixed with scintillation fluid and the 3 H content was determined in a liquid scintillation counter. The radioactive counts were normalized to macrophage protein content. Protein levels in the formic acid lysates of macrophage cultures were determined spectrophotometrically using the detergent-compatible protein assay (DC assay) (Bio-Rad). L-Arginine uptake values were expressed as pmol L-[ 3 H]arginine uptake per mg protein/10 min. Determination of free amino acid levels by HPLC. J774.1 macrophages were processed according to the method described by Fisher et al. (18) . Briefly, after 24 h and 72 h postinfection or -treatment, the macrophages were washed three times with PBS. Then 400 l of 1.5 M perchloric acid (Sigma) was added to each well. The lysed macrophages were scraped off the wells and transferred into a 1.5-ml microcentrifuge tube and the lysates were neutralized by adding 100 l of 2 M potassium hydroxide (Sigma). The samples were cooled on ice for 10 min and then centrifuged at 15,000 ϫ g for 10 min. The supernatants were collected and then filtered through 0.2-m filter units (Millipore) into new 1.5-ml microcentrifuge tubes. Thirty microliters of each sample was then hydrolyzed with 200 l 6 N HCl. The resultant hydrolysate was derivatized to phenylthiocarbamyl (PTC)-amino acids using a precolumn PTC derivatization and analyzed on an Applied Biosystems 420A amino acid analyzer. High-pressure liquid chromatography (HPLC) runs of PTC-labeled amino acid standards were recorded and peak areas calculated to make calibration curves to quantify amino acids in each sample.
Nitrite assay. J774.1 macrophages were cultured in phenol red-free DMEM, supplemented as above. As a measure of NO synthesis, nitrite that accumulated in the culture medium was determined. Nitrite levels were determined by a spectrophotometric assay based on the Greiss reaction (16) . Briefly, 100 l of Greiss reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride in 5% H 3 PO 4 ) was added to a 100-l sample and mixed immediately. After 5 min of incubation at room temperature, absorbance was measured at 540 nm. The nitrite content for each 100-l sample was determined by comparison with a standard curve derived from absorbance readings of freshly made sodium nitrate (Sigma) standards (0 to 1,000 M) dissolved in DMEM, normalized to protein content using the DC protein assay (Bio-Rad), and then expressed as nmol NO per mg protein.
FACS analysis for iNOS protein. J774.1 cells were cultured in 12-well tissue culture plates. Macrophages were infected and treated as described above. Three days after infection or treatment, J774.1 cells were scraped from the bottom of the wells and centrifuged at 800 ϫ g for 10 min. The medium was then removed, and the cells were fixed for 30 min at room temperature with freshly prepared 3.8% paraformaldehyde (Sigma) in PBS. Fixed macrophages were permeabilized with 0.1% Triton X for 1 min and blocked for 15 min in blocking solution (PBS containing 5% [wt/vol] sucrose and 2% [vol/vol] goat serum). Cells were incubated with polyclonal rabbit anti-mouse iNOS antibody for 1 h at 37°C, washed three times in blocking solution, and incubated with fluorescein isothiocyanateconjugated goat anti-rabbit immunoglobulin secondary antibody (Molecular Probes) for 1 h at 37°C. The cells were then washed three times with PBS containing 5% (wt/vol) sucrose. Cells were then resuspended in 500 l PBS and analyzed by fluorescence-activated cell sorting (FACS) using a FACSCalibur (Becton Dickinson) equipped with a 488-nm argon ion laser and a 530-nm band-pass filter. The mean fluorescence intensity for each sample was acquired and analyzed using CellQuest software.
Determination of arginase activity. Arginase activity was determined by measuring the total production of urea in both J774.1 macrophage cell lysates and culture supernatants. After 24 h and 72 h postinfection or -treatment, the macrophage culture supernatants from each well were collected and transferred into 1.5-ml microcentrifuge tubes. The macrophages were then washed three times with PBS, and 500 l of sterile distilled water was added into each well to lyse the cells. Both culture supernatants and macrophage lysates were then filtered through 0.2-m filters.
Urea levels were determined using the blood urea nitrogen reagent kit from ] concentrated sulfuric acid) was added and mixed into each tube and the absorbance was read at 540 nm. The urea levels in the samples were derived from comparison with urea standards and then normalized to protein content using the DC protein assay (Bio-Rad) and expressed as nmol urea per mg protein.
Total RNA extraction and cDNA synthesis. To further characterize the molecular events leading to arginine metabolism in the J774.1 murine macrophage cell line we measured the RNA expression of four genes known to encode enzymes that utilize arginine as their primary substrates. Using real-time PCR, expression levels for MCAT1 and MCAT2 were determined at 6 and 24 h postinfection in J774.1 murine macrophages.
Total RNA from 3 ϫ 10 6 cells (either resting or IFN-␥ plus LPS treated; BCG or AS-1 infected) was isolated using TRIzol reagent (Life Technologies) as specified by the manufacturer, at 6 and 24 h postinfection. Antisense primers were designed using the Primer Express software (version 1.5a; Applied Biosystems) to target specific mRNAs (A/SmCAT1, A/SmCAT2, and A/S␤-actin; Table 1 ). These primers were used for cDNA synthesis at 60°C using C. therm. polymerase (Roche Diagnostics) as specified by the manufacturer.
Real-time PCR. PCR primers were designed to anneal to their targets at 60°C. In order to lower the background during PCR amplification, a tail that hybridizes to the 5Ј end of the primer (bases that are underlined in Table 1 ) was added to the 3Ј end yielding hairpin primers (24) . The specific PCR primers used in this study are the following: FHPmCAT1, RHPmCAT1, FHPmCAT2, RHPmCAT2, FHP␤-actin, and RHP␤-actin (Table 1) .
Plates (384-well) and the Applied Biosystems 7900HT sequence detector system were used for real-time PCR and analysis. Each 5-l reaction mixture contained 1ϫ AmpliTaq Gold polymerase buffer (Perkin-Elmer); 4 mM MgCl 2 ; 2.5 pmol of each primer; 200 M each of dATP, dCTP, dGTP, and dTTP; 0.25 U of AmpliTaq Gold polymerase; 0.5ϫ SYBR green I fluorescent dye (Molecular Probes); and 1.75 ng ROX (6-carboxy-X-rhodamine, succinimidyl ester) as a reference dye. PCR conditions and real-time PCR performance were as previously recommended (24) . External standards for quantitative analysis included 10-fold dilutions (between 10 7 and 10 3 molecules) of single-stranded artificial templates (custom-made oligonucleotides; Invitrogen) with the sequence of the amplicon yielded during the PCR amplification (FTmCAT1, FTmCAT2, FT␤-actin; Table 1 ). Quantitative results for MCAT1 and MCAT2 cDNA were normalized to the number of ␤-actin cDNA molecules measured in parallel. Chromosomal DNA contamination was measured by performance of real-time PCR of "control cDNA" synthesized without the addition of reverse transcriptase. The number of contaminating genomic-DNA molecules was then subtracted from each sample when necessary. Analysis was based on at least three replicates per sample.
Mycobacterial survival studies. BCG-, AS-1-, or AS-2-infected J774.1 cells were harvested at 1 h and 72 h after infection to determine the intracellular viability of BCG. Infected macrophages were harvested by lysis with sterile distilled water. The lysate was serially diluted and plated on 7H11 (Difco) enriched with ADC. Inoculated plates were incubated at 37°C for 3 weeks to allow counting of mycobacterial CFU. For difluoromethylornithine (DFMO) and L-norvaline studies, J774.1 macrophages were pretreated overnight with 1 mM DFMO (Sigma) or 10 mM L-norvaline (Sigma). The next day, cells were washed three times with PBS and incubated with regular DMEM. The cells were then infected with BCG or the AS-1 strain at a multiplicity of infection of 5:1. After 2 h, the infected cells were washed three times with PBS to remove extracellular mycobacteria. IFN-␥ plus LPS and L-ornithine (1 mM) were then added to the appropriate wells. CFU count was determined at an initial time point of 1 or 2 h postinfection and a final time point of 72 h postinfection.
Statistical analysis. Statistical analysis of the data was carried out using StatView software (v. 5), and the statistical significance (P) was determined using the unpaired t test and, for multiple comparisons, Fisher's protected least-significant-difference (PLSD) post hoc test. Differences were considered significant when P was at a level of Ͻ0.05.
RESULTS
An arginine permease mutant strain of BCG (AS-1) induced L-arginine uptake in nonactivated J774.1 murine macrophages. A central response of murine macrophages to activation is the increased accumulation of arginine for the production of NO (5, 6, 7, 26, 31) . We have previously shown that L-arginine uptake by J774.1 murine macrophages is induced 4 h postinfection with AS-1, a BCG strain lacking the L-arginine permease gene Rv0522 (41) . To determine whether increased L-arginine uptake is sustained at a later time point, we measured transport activity by J774.1 cells at 72 h after mycobacterial infection with and without IFN-␥-plus-LPS stimulation. Figure 1 shows that infection with wild-type BCG resulted in a slight (twofold) increase in macrophage L-arginine uptake, but this increase was not significantly different from the uptake of uninfected macrophages (P, 0.1118). In contrast to BCG infection, and consistent with our previous observations, AS-1 infection increased L-arginine uptake of J774.1 cells at 72 h postinfection by approximately 4.4-fold, compared to resting macrophages (P, Ͻ0.0001). As a control, infection of J774.1 cells with AS-2 (the AS-1 strain complemented with a copy of the wild-type Rv0522 gene) resulted in levels of arginine uptake similar to those of BCG-infected macrophages (P, 0.3255). Treatment with IFN-␥ plus LPS in the absence of infection resulted in a fivefold increase in arginine uptake over that of unstimulated macrophages (P, Ͻ0.0001), confirming earlier observations of our and other laboratories (7, 31, 40, 41, 46) . Uptake by AS-1-infected cells showed similar levels of L-arginine uptake to J774.1 macrophages treated with IFN-␥ plus LPS (P, 0.1140). Activation of BCG-, AS-1-, and AS-2-infected macrophages with IFN-␥ plus LPS also resulted in significant increases in arginine uptake (all three conditions have P values of Ͻ0.0001).
AS-1-induced L-arginine uptake was independent of L-arginine-NO pathway. Several studies have shown that increases in L-arginine transport correlate with iNOS induction in macrophage cells (5, 6, 7, 26, 23, 27, 31) . To determine whether the increased cellular uptake of arginine in J774.1 macrophages infected with AS-1 correlates with NO generation, we measured iNOS protein expression by flow cytometry (FACS analysis) and NO production by Greiss assay. Treatment of J774.1 macrophages with IFN-␥ plus LPS induced a 17-fold increase in iNOS protein expression and a 21-fold increase in NO production at 72 h postactivation (Fig.  2) . These increases in iNOS protein expression and activity in IFN-␥-plus-LPS-treated macrophages correlated well with the increased L-arginine uptake shown previously in Fig. 1 , supporting previous observations that L-arginine transport plays a key role in sustaining NO synthesis in activated macrophages (7, 26, 27) .
Although infection with BCG or AS-1 increased iNOS protein expression by 4.6-or 2.4-fold, respectively, there was negligible NO production in these infected cells. Thus, unlike in IFN-␥-plus-LPS-treated macrophages, the induction of L-arginine uptake appears to be uncoupled from iNOS pathway activation.
Infection with both BCG and AS-1 was associated with significant reduction in iNOS protein levels (41%) and NO production (43%) in macrophages activated with IFN-␥ plus LPS, compared to uninfected macrophages treated with IFN-␥ plus LPS. These results suggest that mycobacterial infection suppresses the full induction of iNOS protein expression, leading to lower NO production in IFN-␥-plus-LPS-activated macrophages, as described by Fortune et al. (19) .
AS-1 infection led to increased expression of both MCAT1 and MCAT2 mRNAs in J774.1 macrophages. To investigate the mechanism behind the enhanced uptake of arginine by AS-1-infected macrophages, we quantified the expression of two genes that encode macrophage arginine transporters MCAT1 and MCAT2. Both transporters belong to the murine cationic amino acid family of transporters that are responsible for the transport of arginine, lysine, and ornithine. The MCAT1 transporter is ubiquitously expressed, is found in all tissues except the liver (12), and is responsible for the uptake of arginine for general macrophage metabolism (2, 14) . The MCAT2 product has been shown to be induced in murine macrophages upon stimulation with IFN-␥ plus LPS (17, 30, We examined the transcriptional expression of MCAT1, as shown in Fig. 3 . Treatment with IFN-␥ and LPS significantly decreased the expression of MCAT1 at 24 h compared to resting macrophages (P ϭ 0.0015). This result is consistent with our previous studies (40, 41) and those of MacLeod et al. (34) , where downregulation of MCAT1 mRNA was observed in IFN-␥-plus-LPS-treated macrophages. BCG infection did not significantly change the levels of MCAT1 mRNA in J774.1 macrophages at either time point. MCAT1 mRNA in AS-1-infected macrophages was significantly elevated at 6 h postinfection compared to the levels for resting macrophages (P, 0.0302) and BCG-infected macrophages (P, 0.0068). These results suggest that the enhanced L-arginine uptake detected in AS-1-infected macrophages may be due in part to MCAT1 upregulation. In view of MCAT1's known role in providing arginine for cellular metabolism, these data suggest that AS-1 infection alters the arginine metabolism of the macrophage.
Consistent with previous studies (30, 31, 34) , we observed an approximately sixfold increase in expression of MCAT2 mRNA at 6 h and 24 h posttreatment in IFN-␥-plus-LPStreated macrophages compared to resting macrophages (P, Ͻ0.0001 at both time points) as shown in Fig. 4 . Infection of J774.1 macrophages with either BCG or AS-1 induced a twofold increase in MCAT2 mRNA levels at 6 h postinfection compared to resting macrophages. Therefore, although BCG infection did not significantly induce L-arginine uptake in J774.1 macrophages, it resulted in increased MCAT2 mRNA expression. In contrast, AS-1 infection induced a significant increase in L-arginine uptake and increased expression of both MCAT1 and MCAT2 mRNA levels in J774.1 macrophages. These results suggest that the increased L-arginine uptake in AS-1-infected macrophages is due to the combined upregulation of both MCAT1 and MCAT2 genes.
Intracellular arginine levels were maintained in J774.1 macrophages. We next examined whether intracellular L-arginine levels actually increase due to uptake of exogenous L-arginine in AS-1-infected cells and in IFN-␥-plus-LPS-treated cells. Intracellular free amino acids were extracted using perchloric acid to separate acid-soluble amino acids from precipitated macrophage proteins and then were quantitatively analyzed by HPLC. Figure 5 shows the intracellular levels of arginine and other amino acids in J774.1 macrophage lysates. Among the amino acids analyzed, arginine was the most abundant free amino acid found inside macrophages, with intracellular levels ranging from 350 to 700 pmol per mg total protein, while the intracellular levels of other free amino acids such as lysine and phenylalanine ranged only from 40 to 65 pmol and from 2 to 23 pmol, respectively.
Infection with BCG or AS-1 slightly decreased the intracellular arginine levels, compared to resting macrophages at 24 h postinfection. Treatment with IFN-␥ plus LPS slightly increased intracellular levels of arginine and lysine. However, the overall trend was that BCG or AS-1 infection or treatment with IFN-␥ plus LPS did not significantly alter intracellular levels of free amino acids in J774.1 macrophages. These results suggest that macrophages adapt to maintain arginine levels, as well as those of other amino acids, inside their cells.
Arginase activity was induced by infection and treatment with IFN-␥ plus LPS.
Since we did not find significant changes in the free arginine pools in J774.1 cells during infection with AS-1, we next determined whether AS-1 infection was altering the activities of other arginine-dependent enzymes. In macrophages, arginine is a substrate not only for iNOS but also for arginase, and the two enzymes demonstrate reciprocal regulation (27, 36) . Arginase hydrolyzes arginine to ornithine and urea: urea production is thus an indicator of arginase activity.
To determine the total arginase activity in J774.1 macrophages, total urea production was measured in culture supernatants and macrophage lysates by using a colorimetric assay (29) . Figure 6 shows total urea production in J774.1 macrophages at 24 and 72 h postinfection. Previous studies have shown treatment of murine macrophages with LPS induced arginase expression and activity (42, 43) . Consistent with these studies, we found that urea production was significantly enhanced by three-to fourfold in IFN-␥-plus-LPS-treated macrophages compared to resting macrophages. Infection with BCG and AS-1 also increased urea levels by 0.3-and 0.4-fold, respectively, at 24 h postinfection. Total urea production was further increased by 1.6-and 2.2-fold at 72 h postinfection with BCG and the AS-1 strain, respectively. These results suggest that mycobacterial infection increases arginase activity in J774.1 macrophages. Urea production by AS-1-infected macrophages was higher than that by BCG-infected macrophages at 72 h postinfection. Since AS-1-infected macrophages induced more L-arginine uptake in J774.1 macrophages than did BCG infection, it is likely that L-arginine taken up in AS-1-infected macrophages is metabolized by arginase for ornithine and urea production. Treatment of BCG-or AS-1-infected macrophages with IFN-␥ plus LPS further increased total urea production up to 4.3-to 4.8-fold compared with IFN-␥-plus-LPS-treated macrophages (uninfected) (P, Ͻ0.0001 and 0.0001, respectively). These results suggest that intracellular BCG or AS-1 can further stimulate arginase activity in IFN-␥-plus-LPS-activated macrophages.
Survival studies. We determined whether the changes in L-arginine-dependent pathways have either detrimental or beneficial influence on intracellular survival of BCG or AS-1 in J774.1 macrophages.
To determine the survival of BCG and AS-1 in J774.1 macrophages, intracellular mycobacteria from lysed macrophages with and without IFN-␥-plus-LPS treatment were plated on 7H11 agar. Infection of resting J774.1 macrophages with BCG resulted in a 24% increase in viable colony counts after 72 h, as shown in Fig. 7 (P, 0.4527) . In contrast, AS-1 colony counts significantly increased by 55% after 72 h (P, 0.0321). Stimulation of J774.1 macrophages with IFN-␥ plus LPS resulted in a reduction in viable colony counts of both BCG and AS-1. Thus, both strains were susceptible to IFN-␥-plus-LPS-induced growth inhibition in J774.1 macrophages. However, in the ab- sence of IFN-␥-plus-LPS activation, AS-1 survived significantly better inside resting macrophages than wild-type BCG. DFMO, an inhibitor of ornithine decarboxylase (ODC), promoted mycobacterial survival in resting cells but enhanced mycobacterial growth inhibition in IFN-␥-plus-LPS-activated J774.1 macrophages. In our survival studies we found that AS-1 survives better than wild-type BCG inside resting J774.1 macrophages. We hypothesized that the altered metabolic activities in J774.1 macrophages during infection with AS-1 promoted intracellular survival of AS-1. We have previously shown that there was enhanced macrophage arginase activity in AS-1-infected macrophages compared to BCG-infected macrophages, suggesting an increased diversion of L-arginine into ornithine and urea synthesis. These L-arginine-derived biomolecules are important not only for the host macrophage, but also for intracellular mycobacteria.
DFMO was used to inhibit ODC, blocking ornithine turnover to polyamine synthesis, resulting in buildup of ornithine stores. Ornithine, in turn, inhibits the activity of arginase by feedback inhibition, and therefore, more arginine and ornithine accumulate in the cell. ODC is the first enzyme involved in metabolizing ornithine for polyamine synthesis. ODC activity has also been described in mycobacteria (3, 39) , so it was important to treat J774.1 cells with DFMO before infection. To test the effect of changes in arginine metabolism on the growth of intracellular mycobacteria, we pretreated the J774.1 macrophages with DFMO and then infected the macrophages with BCG or AS-1 and determined the viable colony counts. Figure 8 shows viable colony counts of intracellular BCG and AS-1 from J774.1 macrophages that were treated with and without DFMO and with DFMO plus IFN-␥ plus LPS. Treatment with DFMO greatly enhanced the survival of both BCG and AS-1, resulting in two-and threefold increases in viable colony counts at 72 h, respectively (P values of 0.0009 and 0.0128, respectively).
However, when infected macrophages were treated with DFMO and IFN-␥ plus LPS, there was enhanced killing of intracellular BCG and AS-1 (72% and 77% growth inhibition, respectively). Baydoun et al. (5, 6) showed that treatment of LPS-activated cells with DFMO, which decreased endogenous levels of polyamines, potentiated NO synthesis. Therefore, the enhanced mycobacterial growth inhibition in DFMO-and IFN-␥-plus-LPS-treated macrophages was probably due to amplified NO-dependent growth inhibition.
Effects of exogenous L-ornithine and L-norvaline treatment on intracellular survival of BCG and AS-1 in J774.1 macrophages. To determine whether ornithine levels affect intracellular survival of BCG or AS-1 in J774.1 macrophages, we determined the number of intracellular BCG and AS-1 organisms that survived in J774.1 macrophages growing in culture medium supplemented with L-ornithine. Addition of ornithine to macrophage DMEM did not promote mycobacterial growth of either BCG or AS-1 inside J774.1 macrophages (Fig. 9) .
Since L-ornithine supplementation to J774.1 macrophages did not affect intracellular mycobacterial survival in J774.1 macrophages, we used an arginase inhibitor, L-norvaline, to perturb the intracellular levels of arginine and ornithine inside J774.1 cells. Chang et al. (11) have shown that L-norvaline inhibits arginase activity, reducing urea production by 55% in LPS-activated macrophages. L-Norvaline can directly inhibit arginase because of its structural similarity to ornithine (30) . Ornithine is one of the products of the arginase pathway and it has been shown to exert feedback inhibition of arginase (8, 38) . Inhibition of arginase activity in J774.1 cells has two outcomes: the increase of endogenous arginine levels and the decrease of endogenous ornithine and urea levels. Therefore, L-norvaline treatment may indicate which of these biomolecules contributes to mycobacterial survival within J774.1 macrophages. We predicted that if arginine is more important for mycobacterial survival than ornithine and urea, then intracellular BCG or AS-1 will grow better in L-norvaline-treated cells than in untreated macrophages. On the other hand, if ornithine and urea contribute more to intracellular survival of BCG or AS-1, then growth of BCG or AS-1 should be inhibited in L-norvalinetreated cells.
Treatment of J774.1 macrophages with L-norvaline significantly increased the bacterial numbers of both BCG and AS-1 organisms by five-and sixfold (P, 0.0005 and 0.0042, respectively) after 72 h (Fig. 9) . These results strongly suggest that intracellular survival of mycobacteria might be enhanced by increasing the availability of endogenous arginine inside the host macrophage. L-Norvaline was used to inhibit arginase activity to decrease endogenous ornithine levels inside J774.1 macrophages. We then determined whether exogenous L-ornithine abrogates the effects of L-norvaline treatment on BCG survival within J774.1 macrophages. Supplementation of L-ornithine in L-norvalinetreated J774.1 macrophages was synergistic in promoting intracellular growth of AS-1 (increased from 6-to 8.7-fold) but was antagonistic for BCG (decreased from 5-to 3.7-fold). These results suggest that intracellular growth of wild-type BCG was enhanced by increasing L-arginine availability (norvaline treatment) but not by increasing L-ornithine availability (ornithine supplementation). In contrast, intracellular growth of AS-1 inside J774.1 macrophages was further enhanced by increasing the availability of both L-arginine and L-ornithine. Although the only genotypic difference between AS-1 and BCG was that AS-1 was lacking an L-arginine permease encoded by the Rv0522 gene, it seems that AS-1 has more capacity to metabolize L-ornithine inside J774.1 macrophages than does BCG.
DISCUSSION
Nitric oxide production by murine macrophages is essential for control of mycobacterial infection, and the control of iNOS expression is a hallmark of the success or failure of this process (10, 37) . The amino acid arginine, the sole substrate of iNOS, might be expected to play an influential role during the macrophage's response to infection. In the present study, we report that several macrophage activities related to L-arginine metabolism were altered in response to M. bovis BCG infection and that these alterations are related to the transport capacity of the infecting BCG strain. Infection with the L-arginine permease mutant, AS-1, which lacks the gabP gene (Rv0522), significantly induced L-arginine uptake in J774.1 macrophages. In contrast, infection with wild-type BCG did not alter L-arginine uptake in J774.1 cells. Unlike IFN-␥-plus-LPS stimulation, infection with AS-1 induced L-arginine uptake in J774.1 macrophages independent of NO production. The combined transcriptional upregulation of the MCAT1 and MCAT2 genes encoding cationic amino acid transporters in AS-1-infected macrophages may account for L-arginine uptake greater than that of BCG-infected cells. Furthermore, AS-1-infected macrophages exhibited greater arginase activity than BCG-infected cells. These data suggest that in vitro AS-1 infection upregulates L-arginine consumption toward L-ornithine and urea formation within resting macrophages.
Increased arginine uptake in macrophages would lead to increased substrate availability not only for macrophage metabolism but also for intracellular survival of mycobacteria. Interestingly, we found that J774.1 macrophages have the capacity to maintain high concentrations of free L-arginine either from exogenous or endogenous sources (Fig. 5) . J774.1 macrophages that were either activated by IFN-␥ plus LPS or infected with BCG or AS-1 showed only slight differences in intracellular arginine levels, suggesting that murine macrophages maintain homeostatic levels of intracellular arginine. The capacity of macrophages to metabolize arginine via the arginase and iNOS pathways plays an important role in the regulation of macrophage proliferation and functions. The arginase pathway, as part of the host constructive and reparative program, is important for macrophage proliferation and tissue repair functions. The iNOS pathway, as part of the host defense immune response, is key to the production of NO, a potent antimycobacterial agent and signaling molecule (10, 37). Granger et al. (23) reported that 96% of total L-arginine consumed by resident peritoneal macrophages is utilized through the arginase pathway. The iNOS pathway utilized only 0.7% of total L-arginine in resting macrophages and 30% in activated cells. Consistent with their study, we found that resting J774.1 macrophages exhibited high arginase activity and almost negligible NO synthesis. Activation of J774.1 cells with IFN-␥ plus LPS not only increased NO production by 21-fold but also increased arginase activity by 3-to 4-fold (Fig. 6) .
In resting J774.1 macrophages, intracellular AS-1 survived better than intracellular BCG (Fig. 7) , perhaps because AS-1 infection induced greater arginase activity than BCG infection. In IFN-␥-plus-LPS-activated cells, although infection with either BCG or AS-1 attenuated iNOS protein expression and NO production and enhanced arginase activity, both strains failed to multiply intracellularly within these cells, perhaps because the small amount of NO expressed is sufficient to inhibit the growth of intracellular mycobacteria or because other host defense mechanisms (production of reactive oxygen intermediates, phagosome-lysosome fusion, induction of the LRG-47 pathway, or apoptosis) have also been activated. For other pathogens, such as Trypanosoma cruzi, Leishmania spp., and Schistosoma mansoni, the induction of host arginase activity promotes intracellular survival, not only by attenuating the NO-mediated immune response mounted against them, but also by providing these pathogens with polyamines, which are essential for their growth (1, 20, 28) . Interestingly, in T. cruzi (45) and in Leishmania major (33) , pretreatment of J774.1 cells with N-omega-hydroxy-L-arginine, an arginase inhibitor, resulted in a dramatic decrease in the number of intracellular amastigotes. In contrast, intracellular BCG and AS-1 increased when macrophage arginase activity was inhibited by L-norvaline (Fig. 9) . Furthermore, when macrophage ODC activity (or polyamine synthesis) was inhibited by DFMO, intracellular growth of both BCG and AS-1 was also enhanced (Fig. 8) . These results indicate that intracellular growth of BCG, unlike that of the parasitic pathogens, depends more on the availability of L-arginine and L-ornithine than on polyamines inside the macrophages, as found with the parasites.
The enhanced ability of the AS-1 strain to survive intracellularly within resting J774.1 macrophages may be in part due to its increased capacity to accumulate L-arginine and/or L-arginine-derived substrates while growing within J774.1 macrophages compared to BCG (41) . Since the arginase pathway is the major L-arginine catabolic pathway in resting macrophages, the arginase by-products, L-ornithine and urea, are the major L-arginine-derived biomolecules that intracellular mycobacteria are likely to accumulate inside J774.1 macrophages. Because AS-1 is defective in transporting the cationic amino acid L-arginine but not L-ornithine (44) , perhaps L-ornithine may be preferentially taken up by intracellular AS-1.
Several in vitro observations support our hypothesis that AS-1 has an increased capacity to metabolize ornithine intracellularly compared to BCG. First, AS-1 infection induced greater arginase activity in J774.1 macrophages than BCG infection. This result suggests that there is a greater metabolic demand for L-ornithine and/or urea in AS-1-infected macrophages than in BCG-infected cells. Note that the macrophage culture medium, DMEM, does not contain L-ornithine, and therefore the only source of L-ornithine for J774.1 macrophages is through exogenous L-arginine metabolized via the arginase pathway. We hypothesize that to replenish the intracellular ornithine pools that have been diminished by intracellular AS-1, macrophages take up more L-arginine from the extracellular medium, which can be utilized through the arginase pathway.
Next, when L-norvaline-treated macrophages were supplemented with L-ornithine, intracellular growth of AS-1 increased by 8.7-fold while that of BCG only increased by 3.7-fold at 72 h postinfection. These results suggest that the intracellular growth of AS-1 in J774.1 macrophages can be further enhanced by increasing the availability of ornithine, while survival of BCG does not dramatically change in response to increasing ornithine availability under conditions in which arginine availability is already high.
L-Ornithine can be utilized by intracellular mycobacteria for metabolic processes, such as arginine biosynthesis and polyamine and proline synthesis, that will support mycobacterial growth. The substrate demand for these ornithine-dependent activities is perhaps supported by other cationic amino acid permeases. There are several putative cationic amino acid permeases (encoded by Rv2320c, Rv1999c, and Rv3253c) that (13) , Rv2320c encodes a putative cationic amino acid transporter with possible affinity for the substrates arginine and ornithine. Interestingly, unlike the Rv0522 gene, Rv2320c is found within an operon, rocD 1 D 2 E (Rv2320-Rv2322c), with two rocD gene homologs, which encode ornithine aminotransferases. Such a genetic arrangement suggests that this transporter, since it is coexpressed with the ornithine aminotransferases, mediates the uptake of their substrate, ornithine. Preliminary studies in our laboratory using promoter fusions have suggested that the promoter activity of Rv2320c did not change in the AS-1 mutant during the infection of J774.1 macrophages (40) . However, we cannot exclude the possibility that the activity of this permease is modulated at the posttranscriptional level. Our laboratory is now in the process of creating a Rv2320c deletion mutant strain in both M. bovis BCG and the virulent lab strain M. tuberculosis H37Rv, which will allow us to characterize the specificity and affinity of the mutant strains for transporting arginine, ornithine, and other related amino acids. The strains will also allow us to explore further whether ornithine is a major substrate that is required for intracellular survival in macrophages. Finally, these studies describe an intimate relationship between intracellular mycobacteria and J774.1 macrophages with respect to metabolic currency in the infection process. The results shed light on the complexities inherent in the hostpathogen interaction quite apart from those processes identified by classical searches for virulence factors. Figure 10 shows a more detailed model of how macrophages maintain arginine homeostasis during mycobacterial infection. It summarizes the changes in L-arginine metabolism of murine macrophages infected with either BCG or AS-1. Our studies with this arginine transport mutant have unmasked the importance of L-ornithine in the survival of intracellular mycobacteria, especially under conditions when the bioavailability of L-arginine within the host macrophages is limiting, and thus, access to ornithine may be a regulatory approach to the control of mycobacterial intracellular growth.
